🔴 Inovio Pharmaceuticals is trading 5% down today; catalyst remains unclear

Inovio Pharmaceuticals is trading 5.01% down at $0.85, with no clear company-specific announcement on October 26 explaining the decline.

• The company announced an $80,416,101 court judgment on October 20 and cautioned that defendants’ financial condition may limit collection.
• The judgment does not establish a cause for this session’s move.
• The broader market is higher, so the supplied market context does not explain the drop as a same-direction market move.